Yahoo!
My Yahoo!
Mail
Sign In
[New User?
Sign Up
]
Finance Home
|
Help
Wednesday, February 10, 2010, 9:40pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares,
Register
FINANCE HOME PAGE
INVESTING
FINANCE NEWS
Enter symbol(s):
Market:
Singapore
US
----------------
Argentina
Australia
Austria
Brazil
Canada - Toronto
Canada - Vancouver
China - Shanghai
China - Shenzhen
Denmark
France
Germany XETRA
Germany - Berlin
Hong Kong
India - Bombay
India - National
Indonesia
Israel
Italy
Korea
Korea - KOSDAQ
Malaysia
Mexico
Netherlands
New Zealand
Norway
Spain
Sweden
Switzerland
Taiwan OTC
Taiwan
Thailand
United Kingdom
Search by Company
|
Alphabetical List
K V PHARMA CL B (KV-B)
At 4:59AM SGT:
3.10 USD
0.00 (0.00%)
MORE ON KV-B
Quotes
Summary
Options
Historical Prices
Charts
Basic Chart
Technical Chart
News & Info
Headlines
Company Events
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Insider Trans.
Insider Roster
Financials
Income Statement
Balance Sheet
Cash Flow
K V PHARMA CL B
(NYSE:KV-B) Delayed quote data
Last Trade:
3.10 USD
Trade Time:
4:59AM SGT
Change:
0.00 (0.00%)
Prev Close:
3.10
Open:
N/A
Bid:
N/A
Ask:
N/A
1y Target Est:
N/A
Day's Range:
N/A - N/A
52wk Range:
1.02 - 8.43
Volume:
0
Avg Vol
(3m)
:
5,188.89
Market Cap:
N/A
P/E
(ttm)
:
N/A
EPS
(ttm)
:
N/A
Div & Yield:
N/A (N/A%)
1d
5d
3m
6m
1y
2y
5y
max
Use Y! Toolbar to track stocks
Add KV-B to Portfolio
Download Data
HEADLINES
KV Pharmaceutical Amends Agreement to Secure Rights to Gestiva(TM)
PR Newswire
(Mon, Jan 11)
KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes to Approve Appointment of Director
PR Newswire
(Fri, Jan 8)
KV Pharmaceutical Receives Permission from NYSE for its Securities to Continue Trading on the NYSE until March 31, 2010
PR Newswire
(Wed, Dec 23)
KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent
PR Newswire
(Wed, Dec 16)
KV Pharmaceutical Enters Into Employment Agreement with Interim President and Chief Executive Officer David A. Van Vliet
PR Newswire
(Thu, Dec 3)
KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes To Approve Bylaw Amendments
PR Newswire
(Sat, Nov 14)
Mark & Associates, P.C. Encourages KV Pharmaceutical Shareholders to Explore Legal Rights -- KV-A, KV-B
GlobeNewswire
(Thu, Mar 5)
Mark & Associates, P.C. Encourages KV Pharmaceutical Shareholders to Explore Legal Rights -- KV-A, KV-B
GlobeNewswire
(Thu, Mar 5)
Brower Piven Announces Expanded Class Period and Encourages Investors Who Have Losses in Excess of $150,000 From Investment in KV Pharmaceutical Company to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsuit B
Marketwire
(Fri, Jan 23)
More Headlines for KV-B...
BUSINESS SUMMARY
No business summary available for KV-B.
Add to Portfolio
Email to a Friend
Get
Summary
for Another Symbol:
Singapore
US
----------------
Argentina
Australia
Austria
Brazil
Canada - Toronto
Canada - Vancouver
China - Shanghai
China - Shenzhen
Denmark
France
Germany XETRA
Germany - Berlin
Hong Kong
India - Bombay
India - National
Indonesia
Israel
Italy
Korea
Korea - KOSDAQ
Malaysia
Mexico
Netherlands
New Zealand
Norway
Spain
Sweden
Switzerland
Taiwan OTC
Taiwan
Thailand
United Kingdom
Search by Company
Latest News
Singapore Indices